期刊文献+

AR、NF-κBp65在三阴性乳腺癌中的表达及意义 被引量:3

Expression and Significance of AR and NF-κBp65 in Triple Negative Breast Carcinoma
下载PDF
导出
摘要 目的探讨AR和NF-κBp65在三阴性乳腺癌(TNBC)中的表达及意义。方法采用免疫组织化学EnVision法检测60例TNBC中AR、NF-κBp65的表达情况。结果 60例TNBC中,AR阳性21例(35%),NF-κBp65阳性42例(70%),两者表达无相关性(P=0.324)。AR阳性者组织学分级低(P=0.026)、核分裂多<10/10HPF(P=0.032),NF-κBp65阳性者核分裂多≥10/10HPF(P=0.037),其他临床病理学特征比较无差异。结论 AR、NF-κB在TNBC中有较高的阳性率,可能在肿瘤发生过程中发挥着重要作用,可作为TNBC的治疗靶点。 Objective To investigate the expression and significance of AR and NF-ΚBp65 in triple negative breast carcinoma(TNBC).Methods The expression of AR and NF-ΚBp65 in 60 cases of TNBC were detected by immunohistochemical staining.Results The positive rate of AR was 35% (21/60),and that of NF-ΚBp65 was 70% (42/60),and there was no correlation between them.Compared with clinicopathologic features,AR-positive cases were more likely at lower tumor grade and had less mitosis count(P=0.026,P=0.032,respectively),but NF-κB p65-positive cases had more mitosis count(P=0.037).However,there was no significant difference found between their expressions and the others features.Conclusion AR and NF-κB have high positive rates in TNBC,so they may play critical roles in tumorigenesis of TNBC,and could be new treatment targets.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2010年第12期1416-1419,共4页 Cancer Research on Prevention and Treatment
关键词 乳腺肿瘤 三阴性 AR NF-ΚB 治疗 Breast neoplasms Triple negative AR NF-κB Treatment
  • 相关文献

参考文献1

二级参考文献22

  • 1杨名添,戎铁华,黄植蕃,曾灿光,龙浩,傅剑华,林鹏,王欣,王思愚,王曦,唐军.可手术乳腺癌6263例临床分析[J].癌症,2005,24(3):327-331. 被引量:46
  • 2周晟,刘聪,吴时敏,吴人亮.CD147和MMP-2在乳腺癌组织中的表达及其与预后的相关性[J].癌症,2005,24(7):874-879. 被引量:14
  • 3Buchholz T A, Tu X, Ang K K, et al. Epidermal growth factor receptor expression correlates with poor survival in patients who have breast carcinoma treated with doxorubicinbased neoadjuvant chemotherapy [J]. Cancer, 2005,104(4): 676-681.
  • 4Panigrahi A R, Pinder S E, Chan S Y, et al. The role of PTEN and its signalling pathways, including AKT, in breast cancer: an assessment of relationships with other prognostic factors and with outcome [ J]. J Pathol, 2004,204 ( 1 ) :93- 100.
  • 5Berclaz G, Ahermatt H J, Rohrbach V, et al. EGFR dependent expression of STAT3 (but not STAT1) in breast cancer [J]. Int J Oncol, 2001,19(6): 1155-1160.
  • 6Pianetti S, Marcello A, Romieu-Mourez R, et al. HER-2/neu over-expression induces NF-κB via a PI3-kinase/Akt pathway involving ealpain-mediated degradation of Ikappa B-alpha that can be inhibited by the tumor suppressor PTEN [J]. Oncogene, 2001,20( 11 ) : 1287-1299.
  • 7Hou M F, Lin S B, Yuan S S, et al. The clinical significance between activation of nuclear factor kappa B transcription factor and overexpression of HER-2/neu oncoprotein in Taiwan Residents patients with breast cancer [J]. Clinica Chimica Acta, 2003,334(1-2) : 137-144.
  • 8Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials [J]. Lancet, 2005,365(9472) : 1687-1717.
  • 9Bubendorf L, Nocito A, Moch H, et al. Tissue microarray (TMA) technology: miniaturized pathology archives for highthroughput in situ studies [J]. J Pathol, 2001,195(6) :72-79.
  • 10Malik S N, Brattain M, Ghosh P M, et al.Immunohistochemical demonstration of phospho-akt in high gleason grade prostate cancer [J]. Clin Cancer Res, 2002,8 (4) : 1168-1171.

共引文献9

同被引文献50

引证文献3

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部